1.
Public Health England - Diabetes prevention programmes: evidence review. (2015).
2.
American Diabetes Association - Standards of Medical Care in Diabetes - 2017 Summary of Revisions. Diabetes Care 40, S4–S5 (2017).
3.
NICE - Type 2 diabetes: prevention in people at high risk | Guidance and guidelines.
4.
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. New England Journal of Medicine 346, 393–403 (2002).
5.
Gillies, C. L. et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 334, 299–299 (2007).
6.
Lindstrom, J. et al. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 26, 3230–3236 (2003).
7.
Ramachandran, A. et al. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49, 289–297 (2006).
8.
Tuomilehto, J. et al. Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance. New England Journal of Medicine 344, 1343–1350 (2001).
9.
Matti Uusitupa. Ten-Year Mortality and Cardiovascular Morbidity in the Finnish Diabetes Prevention Study—Secondary Analysis of the Randomized Trial. PLoS ONE 4, (2009).
10.
Brown, J. et al. Lifestyle interventions for the treatment of women with gestational diabetes. in Cochrane Database of Systematic Reviews (John Wiley & Sons, Ltd, 1996). doi:10.1002/14651858.CD011970.pub2.
11.
Carlsson, L. M. S. et al. Bariatric Surgery and Prevention of Type 2 Diabetes in Swedish Obese Subjects. New England Journal of Medicine 367, 695–704 (2012).
12.
Tseng, E., Yeh, H.-C. & Maruthur, N. M. Metformin Use in Prediabetes Among U.S. Adults, 2005?2012. Diabetes Care 40, 887–893 (2017).
13.
Luchsinger, J. A. et al. Metformin, Lifestyle Intervention, and Cognition in the Diabetes Prevention Program Outcomes Study. Diabetes Care 40, 958–965 (2017).
14.
Breeze, P. R. et al. The impact of Type 2 diabetes prevention programmes based on risk-identification and lifestyle intervention intensity strategies: a cost-effectiveness analysis. Diabetic Medicine 34, 632–640 (2017).
15.
Fogelholm, M. et al. PREVIEW: Prevention of Diabetes through Lifestyle Intervention and Population Studies in Europe and around the World. Design, Methods, and Baseline Participant Description of an Adult Cohort Enrolled into a Three-Year Randomised Clinical Trial. Nutrients 9, (2017).
16.
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. New England Journal of Medicine 346, 393–403 (2002).
17.
Gray, L. J., Yates, T., Troughton, J., Khunti, K. & Davies, M. J. Engagement, Retention, and Progression to Type 2 Diabetes: A Retrospective Analysis of the Cluster-Randomised ‘Let’s Prevent Diabetes’ Trial. PLOS Medicine 13, (2016).
18.
A community based primary prevention programme for type 2 diabetes integrating identification and lifestyle intervention for prevention: the Let’s Prevent Diabetes cluster randomised controlled trial- ClinicalKey. https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S0091743515003850.
19.
Barry, E. et al. Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions. BMJ (2017) doi:10.1136/bmj.i6538.
20.
Webb, D. R. et al. Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study. Diabetologia 54, 2237–2246 (2011).
21.
Screening for type 2 diabetes: literature review and economic modelling. Clinical Governance: An International Journal 12, (2007).
22.
Gray, L. J. et al. The Leicester Risk Assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting. Diabetic Medicine 27, 887–895 (2010).
23.
Gray, L. J. et al. Detection of impaired glucose regulation and/or type 2 diabetes mellitus, using primary care electronic data, in a multiethnic UK community setting. Diabetologia 55, 959–966 (2012).
24.
Rajul Parikh,Annie Mathai,Shefali Parikh,G. Chandra Sekhar,Ravi Thomas. Understanding and using sensitivity, specificity and predictive values. Indian Journal of Ophthalmology.
25.
Helen C Eborall. Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial. BMJ : British Medical Journal 335, (2007).
26.
Li, R., Zhang, P., Barker, L. E., Chowdhury, F. M. & Zhang, X. Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review. Diabetes Care 33, 1872–1894 (2010).
27.
Clinical applicability and cost-effectiveness of DIABSCORE in screening for type 2 diabetes in primary care- ClinicalKey. https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S0168822717301031.
28.
Hamman, R. F. et al. Effect of Weight Loss With Lifestyle Intervention on Risk of Diabetes. Diabetes Care 29, 2102–2107 (2006).
29.
Joiner, K. L., Nam, S. & Whittemore, R. Lifestyle interventions based on the diabetes prevention program delivered via eHealth: A systematic review and meta-analysis. Preventive Medicine 100, 194–207 (2017).
30.
Georgios S Papaetis. Incretin-based therapies in prediabetes: Current evidence and future perspectives. World Journal of Diabetes 5, (2014).
31.
Obesity: identification, assessment and management | Guidance and guidelines | NICE.
32.
Health Effects of Overweight and Obesity in 195 Countries over 25 Years. New England Journal of Medicine (2017) doi:10.1056/NEJMoa1614362.
33.
Gregg, E. W. & Shaw, J. E. Global Health Effects of Overweight and Obesity. New England Journal of Medicine (2017) doi:10.1056/NEJMe1706095.
34.
A Systems Science Approach to the Obesity Epidemic and Prevention of Diabetes. (20AD).
35.
Carlsson, L. M. S. et al. Bariatric Surgery and Prevention of Type 2 Diabetes in Swedish Obese Subjects. New England Journal of Medicine 367, 695–704 (2012).
36.
Linda Penn. Importance of Weight Loss Maintenance and Risk Prediction in the Prevention of Type 2 Diabetes: Analysis of European Diabetes Prevention Study RCT. PLoS ONE 8, (2013).
37.
Aguiar, E. J. et al. Efficacy of the Type 2 Diabetes Prevention Using LifeStyle Education Program RCT. American Journal of Preventive Medicine 50, 353–364 (2016).
38.
Effect of a lifestyle intervention on weight change in south Asian individuals in the UK at high risk of type 2 diabetes: a family-cluster randomised controlled trial- ClinicalKey. https://www.clinicalkey.com/#!/content/journal/1-s2.0-S2213858713702043.
39.
Linda Penn. Importance of Weight Loss Maintenance and Risk Prediction in the Prevention of Type 2 Diabetes: Analysis of European Diabetes Prevention Study RCT. PLoS ONE 8, (2013).
40.
Long, G. H. et al. Healthy behaviours and 10-year incidence of diabetes: A population cohort study. Preventive Medicine 71, 121–127 (2015).
41.
Nutrition Recommendations and Interventions for Diabetes: A position statement of the American Diabetes Association. Diabetes Care 31, S61–S78 (2008).
42.
Carter, P., Khunti, K. & Davies, M. J. Dietary Recommendations for the Prevention of Type 2 diabetes: What Are They Based on? Journal of Nutrition and Metabolism 2012, 1–6 (2012).
43.
Pan, X.-R. et al. Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study. Diabetes Care 20, 537–544 (1997).
44.
How to prevent type 2 diabetes in women with previous gestational diabetes? A systematic review of behavioural interventions- ClinicalKey. https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S1751991817300785?returnurl=null&referrer=null.
45.
Malik, V. S. et al. Sugar-Sweetened Beverages and Risk of Metabolic Syndrome and Type 2 Diabetes: A meta-analysis. Diabetes Care 33, 2477–2483 (2010).
46.
Schulze, M. B. Sugar-Sweetened Beverages, Weight Gain, and Incidence of Type 2 Diabetes in Young and Middle-Aged Women. JAMA 292, (2004).
47.
Correction. Circulation 116, e557–e557 (2007).
48.
Malik, V. S., Pan, A., Willett, W. C. & Hu, F. B. Sugar-sweetened beverages and weight gain in children and adults: a systematic review and meta-analysis. American Journal of Clinical Nutrition 98, 1084–1102 (2013).
49.
Deborah F Tate. Replacing caloric beverages with water or diet beverages for weight loss in adults: main results of the Choose Healthy Options Consciously Everyday (CHOICE) randomized clinical trial. The American Journal of Clinical Nutrition 95, (2012).
50.
Pan, A. et al. Red meat consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis. American Journal of Clinical Nutrition 94, 1088–1096 (2011).
51.
Ley, S. H., Hamdy, O., Mohan, V. & Hu, F. B. Prevention and management of type 2 diabetes: dietary components and nutritional strategies. The Lancet 383, 1999–2007 (2014).
52.
Type 2 diabetes: prevention in people at high risk | Guidance and guidelines | NICE.
53.
Emily A Hu. White rice consumption and risk of type 2 diabetes: meta-analysis and systematic review. The BMJ 344, (2012).
54.
Dagfinn Aune. Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies. The BMJ 353, (2016).
55.
Dyson, P. A. et al. Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes. Diabetic Medicine 28, 1282–1288 (2011).
56.
Schwingshackl, L. et al. Food groups and risk of type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies. European Journal of Epidemiology 32, 363–375 (2017).
57.
Mann, J. et al. Dietary guidelines on trial: the charges are not evidence based. The Lancet 388, 851–853 (2016).
58.
Dhingra, R. et al. Soft Drink Consumption and Risk of Developing Cardiometabolic Risk Factors and the Metabolic Syndrome in Middle-Aged Adults in the Community. Circulation 116, 480–488 (2007).
59.
Wu, Y., Zhang, D., Jiang, X. & Jiang, W. Fruit and vegetable consumption and risk of type 2 diabetes mellitus: A dose-response meta-analysis of prospective cohort studies. Nutrition, Metabolism and Cardiovascular Diseases 25, 140–147 (2015).
60.
Diff erences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study. http://ac.els-cdn.com/S2213858714701469/1-s2.0-S2213858714701469-main.pdf?_tid=41970bbc-7e93-11e7-a8e5-00000aab0f01&acdnat=1502455838_1e4678aef6e5b79c43c42f6b68f370f1.
61.
Aune, D., Norat, T., Romundstad, P. & Vatten, L. J. Whole grain and refined grain consumption and the risk of type 2 diabetes: a systematic review and dose–response meta-analysis of cohort studies. European Journal of Epidemiology 28, 845–858 (2013).
62.
Colberg, S. R. et al. Exercise and Type 2 Diabetes: The American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care 33, 2692–2696 (2010).
63.
Yates, T. et al. Stand up for your health: Is it time to rethink the physical activity paradigm? Diabetes Research and Clinical Practice 93, 292–294 (2011).
64.
Steven N Blair. Physical inactivity: the biggest public health problem of the 21st century. British Journal of Sports Medicine 43, 1–2 (2009).
65.
Laaksonen, D. E. et al. Physical Activity in the Prevention of Type 2 Diabetes: The Finnish Diabetes Prevention Study. Diabetes 54, 158–165 (2005).
66.
Thomas Yates. Walking away from type 2 diabetes: trial protocol of a cluster randomised controlled trial evaluating a structured education programme in those at high risk of developing type 2 diabetes. BMC Family Practice 13, (2012).
67.
Colberg, S. R. et al. Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care 39, 2065–2079 (2016).
68.
Stefan, N. et al. A high-risk phenotype associates with reduced improvement in glycaemia during a lifestyle intervention in prediabetes. Diabetologia 58, 2877–2884 (2015).
69.
Less Sitting, More Physical Activity, or Higher Fitness?- ClinicalKey. https://www-clinicalkey-com.ezproxy4.lib.le.ac.uk/#!/content/playContent/1-s2.0-S0025619615006308?returnurl=null&referrer=null.
70.
Sedentary Behaviors and Subsequent Health Outcomes in Adults- ClinicalKey. https://www-clinicalkey-com.ezproxy4.lib.le.ac.uk/#!/content/journal/1-s2.0-S0749379711003126.
71.
LaMonte, M. J. Physical activity and diabetes prevention. Journal of Applied Physiology 99, 1205–1213 (2005).
72.
Church, T. S. et al. Effects of Aerobic and Resistance Training on Hemoglobin A Levels in Patients With Type 2 Diabetes. JAMA 304, (2010).
73.
Orozco, L. J. et al. Exercise or exercise and diet for preventing type 2 diabetes mellitus. in Cochrane Database of Systematic Reviews (John Wiley & Sons, Ltd, 1996). doi:10.1002/14651858.CD003054.pub3.
74.
Sedentary Behaviors and Subsequent Health Outcomes in Adults- ClinicalKey. https://www-clinicalkey-com.ezproxy4.lib.le.ac.uk/#!/content/journal/1-s2.0-S0749379711003126.
75.
Gopalan, A., Lorincz, I. S., Wirtalla, C., Marcus, S. C. & Long, J. A. Awareness of Prediabetes and Engagement in Diabetes Risk?Reducing Behaviors. American Journal of Preventive Medicine 49, 512–519 (2015).
76.
Absetz, P. et al. Type 2 Diabetes Prevention in the Real World: Three-year results of the GOAL Lifestyle Implementation Trial. Diabetes Care 32, 1418–1420 (2009).
77.
Ackermann, R. T., Finch, E. A., Brizendine, E., Zhou, H. & Marrero, D. G. Translating the Diabetes Prevention Program into the Community. American Journal of Preventive Medicine 35, 357–363 (2008).
78.
Sweeting, A. N. et al. Gestational Diabetes Mellitus in Early Pregnancy: Evidence for Poor Pregnancy Outcomes Despite Treatment. Diabetes Care 39, 75–81 (2016).
79.
Koivusalo, S. B. et al. Gestational Diabetes Mellitus Can Be Prevented by Lifestyle Intervention: The Finnish Gestational Diabetes Prevention Study (RADIEL). Diabetes Care 39, 24–30 (2016).
80.
Nathan, D. M. et al. Impaired Fasting Glucose and Impaired Glucose Tolerance: Implications for care. Diabetes Care 30, 753–759 (2007).
81.
Vita, P. et al. Type 2 diabetes prevention in the community: 12-Month outcomes from the Sydney Diabetes Prevention Program. Diabetes Research and Clinical Practice 112, 13–19 (2016).
82.
Breeze, P. R. et al. Cost-effectiveness of population-based, community, workplace and individual policies for diabetes prevention in the UK. Diabetic Medicine 34, 1136–1144 (2017).
83.
The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention: An intent-to-treat analysis of the DPP/DPPOS. Diabetes Care 35, 723–730 (2012).
84.
Bailey, Stephen. Academic Writing : A Handbook for International Students.
85.
Creme, P. & Lea, M. R. Writing At University: A Guide For Students. (McGraw-Hill Education, 2008).
